From a genetic perspective, every cancer is unique. Yet the treatment most patients are offered is a standard treatment based on tissue of origin and stage.
Sequencing has enabled a paradigm shift away from looking at colored cells in a microscope to define the cancer by its genetic drivers enabling the doctor to diagnose aggressive cancers early AND identify more effective treatments for later stage cancers with the same comprehensive sequence based test.
Every year we spend $80 billion on drugs while 8 million patients die because the inconvenient truth is that only 1 out of 4 standard treatments prolong life.
We are over treating early stage cancers because we can't tell if they are going to become aggressive and we are not treating later stage cancers optimally based on the genetic drivers.
We need to change that and we can - with ONE test